A decision to approve new medicines to treat Duchenne muscular dystrophy and a rare life-threatening blood disease for use in ...
Please provide your email address to receive an email when new articles are posted on . Ravulizumab led to maintained control of intravascular hemolysis and sustained stable hemoglobin levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback